Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Merck to buy Peloton Therapeutics

Merck & Co., Inc., a pharmaceutical company based in the United States, has agreed to buy Peloton Therapeutics Inc for $1.05 billion in cash, Reuters reported. Peloton Therapeutics is a biopharmaceutical company that develops medicines for patients with cancer and other debilitating or life-threatening conditions. Credit Suisse advised Merck on the transaction.


Mergers and Acquisitions,M&A,M&A deals